世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035311

鎮痙薬の世界市場レポート(2023年)

The Business Research Company

Antispasmodics Drugs Global Market Report 2023

発刊日 2023/05/16

言語英語

体裁PDF/250ページ

ライセンス/価格250ページ

0000035311

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、鎮痙薬の世界市場に関して、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げている鎮痙薬市場に焦点を当て、今後10年およびそれ以降の市場を形成するトレンドについてのガイドを提供します。

調査範囲

  • 調査市場
    ➣ 薬剤別
      ◇ ジシクロミン塩酸塩
      ◇ ロペラミド塩酸塩
      ◇ その他の薬剤
    ➣ 適応症別
      ◇ 過敏性腸症候群
      ◇ 胃けいれん
      ◇ その他の適応症
    ➣ 投与経路別
      ◇ 経口
      ◇ 非経口
      ◇ その他の投与経路
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ オンライン薬局
      ◇ 小売薬局
    ➣ エンドユーザー別
      ◇ 病院
      ◇ ホームケア
      ◇ 専門クリニック
      ◇ その他のエンドユーザー
  • 調査企業
    ➣ 第一三共(Daiichi Sankyo Company Limited)
    ➣ Fresenius Kabi A
    ➣ Hikma Pharmaceuticals Plc.
    ➣ Johnsons & Johnsons Services Inc.
    ➣ Pfizer Inc.
  • 調査国
    ➣ オーストラリア
    ➣ ブラジル
    ➣ 中国
    ➣ フランス
    ➣ ドイツ
    ➣ インド
    ➣ インドネシア
    ➣ 日本
    ➣ ロシア
    ➣ 韓国
    ➣ イギリス
    ➣ アメリカ
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
  • 提供形態
    ➣ PDF、Word、Excelデータダッシュボード

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Antispasmodics Drugs Market Characteristics

3. Antispasmodics Drugs Market Trends And Strategies

4. Antispasmodics Drugs Market - Macro Economic Scenario
4.1. COVID-19 Impact On Antispasmodics Drugs Market
4.2. Ukraine-Russia War Impact On Antispasmodics Drugs Market
4.3. Impact Of High Inflation On Antispasmodics Drugs Market

5. Antispasmodics Drugs Market Size And Growth
5.1. Global Antispasmodics Drugs Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Antispasmodics Drugs Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Antispasmodics Drugs Market Segmentation
6.1. Global Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Dicyclomine Hydrochloride
Loperamide Hydrochloride
Other Drugs
6.2. Global Antispasmodics Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Irritable Bowel Syndrome
Stomach Cramps
Other Indications
6.3. Global Antispasmodics Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Oral
Parenteral
Other Modes Of Administrations
6.4. Global Antispasmodics Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmnacy
6.5. Global Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End-Users

7. Antispasmodics Drugs Market Regional And Country Analysis
7.1. Global Antispasmodics Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Antispasmodics Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Antispasmodics Drugs Market
8.1. Asia-Pacific Antispasmodics Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Antispasmodics Drugs Market
9.1. China Antispasmodics Drugs Market Overview
9.2. China Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Antispasmodics Drugs Market
10.1. India Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Antispasmodics Drugs Market
11.1. Japan Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Antispasmodics Drugs Market
12.1. Australia Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Antispasmodics Drugs Market
13.1. Indonesia Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Antispasmodics Drugs Market
14.1. South Korea Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Antispasmodics Drugs Market
15.1. Western Europe Antispasmodics Drugs Market Overview
15.2. Western Europe Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Antispasmodics Drugs Market
16.1. UK Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Antispasmodics Drugs Market
17.1. Germany Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Antispasmodics Drugs Market
18.1. France Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Antispasmodics Drugs Market
19.1. Eastern Europe Antispasmodics Drugs Market Overview
19.2. Eastern Europe Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Antispasmodics Drugs Market
20.1. Russia Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Antispasmodics Drugs Market
21.1. North America Antispasmodics Drugs Market Overview
21.2. North America Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Antispasmodics Drugs Market
22.1. USA Antispasmodics Drugs Market Overview
22.2. USA Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Antispasmodics Drugs Market
23.1. South America Antispasmodics Drugs Market Overview
23.2. South America Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Antispasmodics Drugs Market
24.1. Brazil Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Antispasmodics Drugs Market
25.1. Middle East Antispasmodics Drugs Market Overview
25.2. Middle East Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Antispasmodics Drugs Market
26.1. Africa Antispasmodics Drugs Market Overview
26.2. Africa Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Antispasmodics Drugs Market Competitive Landscape And Company Profiles
27.1. Antispasmodics Drugs Market Competitive Landscape
27.2. Antispasmodics Drugs Market Company Profiles
27.2.1. Daiichi Sankyo Company Limited
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Fresenius Kabi AG
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Hikma Pharmaceuticals Plc.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Johnsons & Johnsons Services Inc.
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Pfizer Inc.
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Antispasmodics Drugs Market

29. Antispasmodics Drugs Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. The Business Research Company
30.6. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global Antispasmodics Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global Antispasmodics Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 6: Global Antispasmodics Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 7: Global Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 8: Global Antispasmodics Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 9: Global Antispasmodics Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 10: Asia-Pacific, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 11: Asia-Pacific, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 12: China, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 13: China, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 14: India, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 15: India, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 16: Japan, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 17: Japan, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 18: Australia, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 19: Australia, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 20: Indonesia, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 21: Indonesia, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 22: South Korea, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 23: South Korea, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 24: Western Europe, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 25: Western Europe, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 26: UK, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 27: UK, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 28: Germany, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 29: Germany, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 30: France, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 31: France, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 32: Eastern Europe, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 33: Eastern Europe, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 34: Russia, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 35: Russia, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 36: North America, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 37: North America, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 38: USA, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 39: USA, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 40: South America, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 41: South America, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 42: Brazil, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 43: Brazil, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 44: Middle East, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 45: Middle East, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 46: Africa, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 47: Africa, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 48: Daiichi Sankyo Company Limited Financial Performance
Table 49: Fresenius Kabi AG Financial Performance
Table 50: Hikma Pharmaceuticals Plc. Financial Performance
Table 51: Johnsons & Johnsons Services Inc. Financial Performance
Table 52: Pfizer Inc. Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Figure 3: Global Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 4: Global Antispasmodics Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 5: Global Antispasmodics Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 6: Global Antispasmodics Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 7: Global Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 8: Global Antispasmodics Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 9: Global Antispasmodics Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 10: Asia-Pacific, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 11: Asia-Pacific, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 12: China, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 13: China, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 14: India, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 15: India, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 16: Japan, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 17: Japan, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 18: Australia, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 19: Australia, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 20: Indonesia, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 21: Indonesia, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 22: South Korea, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 23: South Korea, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 24: Western Europe, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 25: Western Europe, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 26: UK, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 27: UK, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 28: Germany, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 29: Germany, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 30: France, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 31: France, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 32: Eastern Europe, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 33: Eastern Europe, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 34: Russia, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 35: Russia, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 36: North America, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 37: North America, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 38: USA, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 39: USA, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 40: South America, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 41: South America, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 42: Brazil, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 43: Brazil, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 44: Middle East, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 45: Middle East, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 46: Africa, Antispasmodics Drugs Market, Segmentation By Drug, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 47: Africa, Antispasmodics Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 48: Daiichi Sankyo Company Limited Financial Performance
Figure 49: Fresenius Kabi AG Financial Performance
Figure 50: Hikma Pharmaceuticals Plc. Financial Performance
Figure 51: Johnsons & Johnsons Services Inc. Financial Performance
Figure 52: Pfizer Inc. Financial Performance

この商品のレポートナンバー

0000035311

TOP